MWM
RPRX icon

Moran Wealth Management’s Royalty Pharma RPRX Stock Holding History

Moran Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
186,672
+10,850
+6% +$565K 0.29% 117
2026
Q1 		$8.43M Buy
175,822
+38,629
+28% +$1.69M 0.26% 132
2025
Q4 		$5.3M Buy
137,193
+23,429
+21% +$893K 0.16% 191
2025
Q3 		$4.01M Buy
113,764
+29,231
+35% +$1.06M 0.12% 206
2025
Q2 		$3.05M Sell
84,533
-4,458
-5% -$148K 0.09% 251
2025
Q1 		$2.77M Buy
+88,991
New +$2.82M 0.09% 243

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moran Wealth Management's RPRX Position: Q2 2026 in Review

Moran Wealth Management increased its Royalty Pharma (RPRX) stake by 6.2% in Q2 2026, buying an estimated $565K and bringing the position to 186,672 shares worth $10.5M. The position accounts for 0.29% of the portfolio, ranked #117.

Moran Wealth Management first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Moran Wealth Management held 186,672 shares of Royalty Pharma worth $10.5M as of Q2 2026.
  • Moran Wealth Management bought 10,850 Royalty Pharma shares in Q2 2026, an estimated $565K.
  • Royalty Pharma made up 0.29% of Moran Wealth Management's portfolio in Q2 2026, its #117 holding.
  • Moran Wealth Management first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.